FDA cleared the BedDot (G1) from Intelligent Dots, LLC on Jun 25, 2026 under K253274, a traditional 510(k). The device falls under product code BZQ, Monitor, Breathing Frequency, regulated at 21 CFR 868.2375 as a Class 2 device. The review panel was Anesthesiology.

FDA logged the submission as received on Sep 29, 2025. The decision came 269 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

This is the only decision on file for Intelligent Dots, LLC in the last 12 months of the tracker.